Atopic dermatitis — commonly called eczema — is one of the most common chronic conditions of childhood, affecting approximately one in five children in the UK. It most frequently presents in the first year of life, often in the first weeks to months, and may persist into childhood and adolescence or clear completely in the early years. For many families, infant eczema is a significant source of anxiety and practical difficulty: the itching disrupts sleep, the inflammation looks alarming, and the management involves daily effort.
Understanding what eczema is, why it occurs, and how it is most effectively managed — including how to use the treatments that work — helps parents approach their child's eczema with more confidence and less distress.
Healthbooq provides parents with evidence-based guidance on infant skin conditions, including practical emollient use, topical steroid guidance, and when referral is appropriate.
What Atopic Dermatitis Is
Atopic dermatitis is fundamentally a condition of the skin barrier. In eczema, the natural barrier function of the skin — which normally prevents water loss and keeps environmental irritants and allergens out — is impaired. This leads to dry skin, vulnerability to irritation from contact with everyday substances, and an exaggerated inflammatory response. The skin becomes red, itchy, and inflamed; scratching damages it further, leading to weeping, crusting, and secondary bacterial infection.
The condition is genetic: children with a personal or family history of eczema, asthma, or hayfever (the "atopic triad") are more likely to develop it. It is not caused by diet in most cases, though food allergy (particularly cow's milk and egg) can exacerbate eczema in some children with established atopic dermatitis. It is not contagious.
In infants, eczema typically appears first on the cheeks, forehead, and scalp — areas the baby cannot scratch — and on the extensor surfaces of the arms and legs. As children grow, it characteristically involves the flexures (inside of elbows, behind the knees, wrists, and ankles).
Emollient Therapy
The foundation of eczema management is regular, generous emollient use. Emollients — moisturisers — work by replacing the deficient skin barrier function, reducing water loss, and reducing the frequency and severity of flares. The evidence is clear that more emollient use produces better eczema control.
The key principles of emollient use are: apply at least twice daily (or more frequently during flares and after bathing); apply to the whole body, not just visibly dry areas; use generous quantities (for a young child, this may be 250g per week); apply with gentle, downward strokes (not rubbing); and use the emollient both after bathing and at other times throughout the day. Bath time should involve a short soak (ten minutes maximum) in lukewarm water with an emollient wash product substituted for soap, followed by immediate emollient application while the skin is still slightly damp to seal moisture in.
Parents should try different emollients to find one that works — different textures (creams, ointments, lotions) suit different children and different seasons. Ointments (such as 50:50 white soft paraffin/liquid paraffin) provide superior barrier function but feel greasier; creams balance efficacy and cosmetic acceptability. Emollients from the GP are available on prescription and are free to children; the cost of purchasing adequate quantities over the counter is significant.
Topical Corticosteroids
For active eczema flares, topical corticosteroids are the most effective anti-inflammatory treatment. Despite significant parental anxiety about steroid use, topical corticosteroids used appropriately are safe and effective; steroid phobia — fear of using topical steroids based on misunderstanding of the evidence — is a significant cause of undertreated eczema and unnecessary suffering.
The potency of topical corticosteroid used should match the severity of the eczema: mild eczema on the body uses mild steroids (hydrocortisone 1%); moderate eczema uses moderate-potency steroids (clobetasone butyrate 0.05%); potent steroids are used for severe eczema and are prescribed by a GP or dermatologist. Facial eczema in infants should generally be treated only with mild-potency steroids. The steroid should be applied once daily (usually in the evening) to areas of active flare — red, itchy, inflamed skin — and continued for two days after the skin has cleared, rather than stopped as soon as visible improvement occurs, to prevent rapid relapse.
The risk of skin thinning from topical steroids is real but greatly overstated in public perception. Skin thinning results from prolonged daily use of potent steroids on thin-skinned areas; intermittent use of appropriate-potency steroids for active flares does not carry this risk.
Infected Eczema
Eczema is frequently colonised by Staphylococcus aureus, which contributes to inflammation. Frank secondary infection — often presenting as weeping, crusted, golden-yellow patches, or sudden unexplained worsening — may require oral antibiotics. A child whose eczema is not responding to usual management, or who has visible signs of infection, should be seen by a GP.
Key Takeaways
Atopic dermatitis (eczema) affects around one in five children in the UK and most commonly presents in the first year of life. It is a chronic condition of the skin barrier characterised by dry, itchy, inflamed skin that flares and remits. The mainstay of management is regular, generous application of emollient (moisturiser) to maintain the skin barrier, and use of topical corticosteroids to treat active flares. Early, proactive emollient use is the most evidence-based strategy for managing eczema, and steroid phobia — avoidance of topical corticosteroids due to unfounded concerns about safety — leads to undertreated eczema and unnecessary suffering.
